Using automated machine learning to predict the next monoclonal antibodies ( MAB) to be approved by the Food and Drug Administration (FDA) | by SIONG JONG HANG | Towards Data Science
Switchable assembly and function of antibody complexes in vivo using a small molecule | PNAS
Frontiers | Phage Display Derived Monoclonal Antibodies: From Bench to Bedside | Immunology
Personalized Cancer Therapy Immunotherapy - ppt download
SciELO - Brasil - Advances and challenges in therapeutic monoclonal antibodies drug development Advances and challenges in therapeutic monoclonal antibodies drug development
Therapeutic Antibodies丨Antibody Therapy-GenScript
How monoclonal antibodies fight COVID-19 - University of Mississippi Medical Center
Full article: Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980–2016)
Advances and challenges in therapeutic monoclonal antibodies drug development
Weiner Building better monoclonal antibody-based therapeutics. Nature... | Download Scientific Diagram
Definition of monoclonal antibody - NCI Dictionary of Cancer Terms - NCI
Building better monoclonal antibody-based therapeutics. - Abstract - Europe PMC
Building better magic bullets — improving unconjugated monoclonal antibody therapy for cancer | Nature Reviews Cancer
Monoclonal Antibodies - NCI
Antibodies | Free Full-Text | Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients | HTML
Antibodies | Free Full-Text | Monoclonal Antibodies in Cancer Therapy | HTML
Development of therapeutic antibodies for the treatment of diseases | Journal of Biomedical Science | Full Text
Building better monoclonal antibody-based therapeutics | Nature Reviews Cancer
State-funded monoclonal antibody treatment center opens in Fort Worth. Here's what you need to know about the treatment.
Expanding access to monoclonal antibody-based products
Building better monoclonal antibody-based therapeutics - Document - Gale Academic OneFile
Evidence-Based Recommendations on the Use of Anti-SARS-CoV-2 Monoclonal Antibodies (Casirivimab + Imdevimab, and Sotrovimab) for Adults in Ontario - Ontario COVID-19 Science Advisory Table
Building better monoclonal antibody-based therapeutics
Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge - ScienceDirect
